Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β(2)-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis

INTRODUCTION: Triple inhaled corticosteroid/long-acting muscarinic antagonist/long-acting β(2)-agonist (ICS/LAMA/LABA) combination therapy is recommended for patients with chronic obstructive pulmonary disease (COPD) who experience further exacerbations/symptoms on dual LAMA/LABA or ICS/LABA therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferguson, Gary T., Darken, Patrick, Ballal, Shaila, Siddiqui, Mohd Kashif, Singh, Barinder, Attri, Sumeet, Holmgren, Ulf, de Nigris, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467454/
https://www.ncbi.nlm.nih.gov/pubmed/32335859
http://dx.doi.org/10.1007/s12325-020-01311-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467454/
https://www.ncbi.nlm.nih.gov/pubmed/32335859
http://dx.doi.org/10.1007/s12325-020-01311-3

Ejemplares similares